Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_assertion type Assertion NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_head.
- NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_assertion wasGeneratedBy ECO_0000203 NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_provenance.
- NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_assertion wasDerivedFrom befree-20140225 NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_provenance.
- NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_assertion SIO_000772 19734903 NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_provenance.
- NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_assertion evidence source_evidence_literature NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_provenance.
- NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_assertion description "[Previous biological studies support roles of CLU and CR1 in the clearance of beta amyloid (Abeta) peptide, the principal constituent of amyloid plaques, which are one of the major brain lesions of individuals with Alzheimer's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424318.RASOoya4mC8hVQz43MNuA-7H2GHnlR8h0GPSfvVCpn1gc130_provenance.